Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endogenex PULSE Registry

NCT07197775 is registered in ClinicalTrials.gov with Endogenex, Inc. as lead sponsor.

NCT NCT07197775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07197775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endogenex PULSE Registry
Lead sponsor
Endogenex, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 11, 2026
Completion date
May 31, 2032
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2, type 2 diabetes, type 2 diabetes mellitus (t2dm), type2diabetes